Viatris Announces the Pricing Terms of Maximum Tender Offer

September 18, 2024 UCBN News, Syndication Comments Off on Viatris Announces the Pricing Terms of Maximum Tender Offer

PITTSBURGH, Sept. 18, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS, “Viatris” or the “Company”) announced today the pricing terms of the previously announced cash tender offer (the “Maximum Tender Offer”) of its subsidiary Utah Acquisition Sub Inc. (“UAS”) for up to an increased…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Related Articles

No Picture
News

BlueWind Medical to Present Positive Results from its Pivotal Trial in Patients with Overactive Bladder at the 2023 AUA Annual Meeting

April 24, 2023 UCBN News Comments Off on BlueWind Medical to Present Positive Results from its Pivotal Trial in Patients with Overactive Bladder at the 2023 AUA Annual Meeting

PARK CITY, Utah, April 24, 2023 /PRNewswire/ — BlueWind Medical, Ltd., the developer of transformative implantable tibial neuromodulation therapy for Overactive Bladder (OAB), today announced that efficacy results of the OASIS pivotal clinical study will […]

News

CivicaScript announces availability of low-cost insulin and biosimilar for chronic inflammatory conditions in the US

January 5, 2026 UCBN News, Syndication Comments Off on CivicaScript announces availability of low-cost insulin and biosimilar for chronic inflammatory conditions in the US

New additions expand company’s rapidly growing product portfolio LEHI, Utah, Jan. 5, 2026 /PRNewswire/ — CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, today announced the availability […]